Who
Kevin G. Lokay
Director
Company insider
Files Form 4 as: Director, Galera Therapeutics; CEO, President & Director, Cytogen.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 14 Jun 2006
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —240 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —240 | filing |
| 24 Feb 2025filed 26 Feb 2025 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 15 Jun 2022filed 16 Jun 2022 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 16 Jun 2021filed 17 Jun 2021 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,888 at $0.00 | filing |
| 9 Jun 2020filed 10 Jun 2020 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,888 at $0.00 | filing |
| 8 May 2008filed 9 May 2008 | Cytogenoption or derivative | SEC FORM 4 Code D | —400,000 | filing |
| 8 May 2008filed 9 May 2008 | Cytogenoption or derivative | SEC FORM 4 Code D | —100,000 | filing |
| 8 May 2008filed 9 May 2008 | Cytogen | SEC FORM 4 Code D | —11,836 | filing |
| 8 May 2008filed 9 May 2008 | Cytogen | SEC FORM 4 Code D | —185,439 | filing |
| 13 Nov 2007filed 15 Nov 2007 | Cytogenoption or derivative | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 13 Nov 2007filed 15 Nov 2007 | Cytogenoption or derivative | SEC FORM 4 Code A | —350,877 at $0.00 | filing |
| 13 Nov 2007filed 15 Nov 2007 | Cytogenoption or derivative | SEC FORM 4 Code A | —175,439 at $0.00 | filing |
| 14 Jun 2007filed 15 Jun 2007 | Cytogenoption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 13 Jun 2007filed 15 Jun 2007 | Cytogen | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 14 Jun 2006filed 15 Jun 2006 | Cytogenoption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.